Press Releases - Business Wire China

Press Releases

2017-12-12 16:21 World’s First Ultra HD HDR Travel Channel Travelxp 4K Makes German Debut on HD+ via SES

2017-12-12 16:18 The Country Network (TCN) Debuts in Ultra HD with SES

2017-12-12 15:58 Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

2017-12-12 15:21 Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses

2017-12-12 15:16 Dr Amal Al Qubaisi Wins Parliamentarian Excellence Award as Best President of Arab Parliament

2017-12-12 10:15 Moody’s Analytics wins Technology Vendor of the Year in Risk Awards

2017-12-12 10:03 NTT Communications Strengthens its DDoS Protection Services with New Detection Solution

2017-12-12 10:01 NTT Communications Addresses Network and Cyber Security at Capacity Asia 2017

2017-12-12 09:59 Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

2017-12-12 09:56 4KUNIVERSE to Launch in Swiss TV Households via SES

2017-12-11 17:57 Mitsui Chemicals - Completion of Expansion of Electrolyte Solution Production Capacity in China

2017-12-11 17:51 Oasis Response to Alpine’s December 4, 2017 Statement & Presentation

2017-12-11 14:03 Bertin and Zymo Research Announce New Collaboration

2017-12-11 13:26 Herbalife Nutrition Appoints Renowned Thai Sports Medicine Expert to Its Nutrition Advisory Board

2017-12-11 10:29 Toshiba Electronic Devices & Storage Corporation Launches World's First 14TB HDD with Conventional Magnetic Recording

2017-12-11 10:26 AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials

2017-12-11 10:23 Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting

2017-12-11 10:21 AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial

2017-12-11 10:17 A.M. Best Affirms Credit Ratings of China Reinsurance (Group) Corporation and Its Subsidiaries

2017-12-08 18:48 World Robotics Federation IFR Elected Junji Tsuda as New President

Shanghai Office

Rm 1502 Xincheng Mansion, No. 167 Jiangning Rd, Shanghai, China

+86 21 5239 8905

sh@businesswirechina.com

Business Wire Hong Kong

51/F Hopewell Centre, 183 Queen's Road East
Wan Chai, Hong Kong

+852 3602 3091

hk@businesswire.com

© 2008-2016 Interfax Business Wire Service, all rights reserved.